首页> 外文期刊>International Journal of Medicinal Mushrooms >28-Day Oral Safety Evaluation of Extracellular Polysaccharopeptides Produced in Submerged Culture from the Turkey Tail Medicinal Mushroom Trametes versicolor (L.:Fr.) Pilat LH-1 in Mice
【24h】

28-Day Oral Safety Evaluation of Extracellular Polysaccharopeptides Produced in Submerged Culture from the Turkey Tail Medicinal Mushroom Trametes versicolor (L.:Fr.) Pilat LH-1 in Mice

机译:土耳其尾部杂色蘑菇菇Tramates L.L-1小鼠在水下培养中产生的细胞外多糖肽的28天口服安全性评估

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Turkey tail medicinal mushroom, Trametes versicolor (TV), is a species with a variety of pharmacological activities. Its intracellular polysaccharopeptides are widely commercialized. Recently, we found a novel TV strain LH-1 in Taiwan and demonstrated that the extracellular polysaccharopeptide (ePSP) of LH-1 obtained from submerged culture exhibits significant immunomodulatory activity. In this in vivo study, we further evaluated the safety of orally administered LH-1 ePSP using both male and female ICR mice. The LH-1 ePSP was orally administered to mice at levels of 0 (water), 100 (low dose), 500 (medium dose), or 1000 mg/kg/day (high dose) for 28 days. Clinical observations, growth, food consumption, histopathological examination, and clinical biochemical analyses revealed no adverse effects of LH-1 ePSP in mice. There were no significant differences in the results of target organ weights, hematological analyses, and urinalysis examination among groups. However, male mice that ingested high doses of LH-1 ePSP tended to have decreased lung weights and platelet numbers. In conclusion, the results of the present study suggested that oral administration of LH-1 ePSP for 28 days is accompanied by no obvious signs of toxicity. The lack of toxicity supports the potential use of LH-1 ePSP as a food or dietary supplement.
机译:土耳其尾药用蘑菇Trametes versicolor(TV),是一种具有多种药理活性的物种。其细胞内多糖肽已广泛商业化。最近,我们在台湾发现了一种新型电视菌株LH-1,并证明了从淹没培养物中获得的LH-1的胞外多糖肽(ePSP)表现出显着的免疫调节活性。在这项体内研究中,我们进一步评估了使用雄性和雌性ICR小鼠口服给予的LH-1 ePSP的安全性。将LH-1 ePSP以0(水),100(低剂量),500(中剂量)或1000 mg / kg /天(高剂量)的水平口服给予小鼠28天。临床观察,生长,食物消耗,组织病理学检查和临床生化分析表明,LH-1 ePSP对小鼠没有不利影响。各组的目标器官重量,血液学分析和尿液检查结果无显着差异。但是,摄入高剂量LH-1 ePSP的雄性小鼠倾向于减少肺重量和血小板数量。总之,本研究的结果表明,口服LH-1 ePSP 28天没有明显的毒性迹象。缺乏毒性支持将LH-1 ePSP潜在地用作食品或膳食补充剂。

著录项

相似文献

  • 外文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号